Patent ID: 11857617
Assignee: TOPELIA AUST LIMITED (652 771 670)
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A  C

Claim 8:
9. The method of claim 1, wherein the anti-viral drug combination, and/or the live, inactivated or attenuated causative agent of the infection, is administered or formulated:
(a) orally or by inhalation, or is administered by inclusion in a liquid;
(b) as a drink or in drops, wherein optionally the drops comprise nasal drops;
(c) in a mist formulation;
(d) as a tablet, a capsule, a gel, a geltab, a powder, a lozenge, an aerosol, spray, or mist formulation that is inhaled or administered nasally or orally;
(e) by or using a puffer or a nebulizer; or
(f) in a liquid, wherein optionally the liquid is a sterile saline solution which is ingested or gargled by the individual in need thereof.